Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Massive ALS data bank launches to speed up search for cure

NCT ID NCT05204017

First seen May 01, 2026 · Last updated Jun 23, 2026 · Updated 11 times

Summary

This study is building a large collection of data and biological samples from 150 people with ALS and related disorders. Researchers will track changes in muscle function, breathing, speech, brain scans, and quality of life over time. The goal is to create a shared resource that scientists worldwide can use to better understand ALS and develop new treatments.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AMYOTROPHIC LATERAL SCLEROSIS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • CHU de Quebec -Universite de Laval

    RECRUITING

    Québec, Quebec, G1J 1Z, Canada

  • McGill University / Montreal Neurological Institute and Hospital

    RECRUITING

    Montreal, Quebec, H4A2H6, Canada

  • University of Alberta

    RECRUITING

    Edmonton, Alberta, T6G 2B7, Canada

  • University of Toronto / Sunnybrook Health Sciences Centre

    RECRUITING

    Toronto, Ontario, M4N 3M5, Canada

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this platform could provide researchers worldwide with the data needed to develop better treatments or even a cure for ALS.

What could go wrong

This is an observational study, not a treatment trial. It may not directly benefit participants and could take years to yield actionable results.

Conditions

The condition(s) this trial relates to.

amyotrophic lateral sclerosis Disease Progression motor neuron disorder spinal muscular atrophy

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.